Table 1.
Disease characteristics of the 62 patients with newly diagnosed Graves disease who underwent a magnetic resonance investigation at inclusion
| No. | Median (IQR) or n (%) | |
|---|---|---|
| Time from blood test before diagnosis to inclusion, d | 61 | 13 (11.0-19.0) |
| Time from start of antithyroid drugs to blood test at inclusion, d | 62 | 8 (6-13) |
| Duration of symptoms before diagnosis, mo | 60 | 4 (3.0-6.2) |
| Patients treated with β-blockers | 62 | 48 (77.4) |
| Patients treated with antithyroid drugs | 62 | 62 (100) |
| Tiamazole | 62 | 60 (96.8) |
| Propylthiouracil | 62 | 2 (3.2) |
| Eye evaluation with clinical activity score > 3 | 62 | 0 |
Abbreviation: IQR, interquartile range.